Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Ais Larisgoitia, A."'
Autor:
Chamorro-de-Vega, Esther, Calvo, Alberto, Fernández-Pacheco, María, Hernández-Muniesa, Belén, Romero-Jiménez, Rosa, Casado-Gómez, Araceli, Ramírez, Esther, Morell, Alberto, Herrero, Nuria, Úbeda, Bárbara, Ais-Larisgoitia, Arantza, Lobato-Matilla, Elena, Muñoz, Álvaro, Casado, Miguel Ángel, Escudero-Vilaplana, Vicente
Publikováno v:
In Farmacia Hospitalaria November-December 2024 48(6):265-271
Autor:
Ibarra Barrueta, Olatz, García Martín, Estela, López Sánchez, Piedad, Ramírez Herráiz, Esther, Merino Bohórquez, Vicente, Ais Larisgoitia, Arantza
Publikováno v:
In Farmacia Hospitalaria January-February 2023 47(1):T39-T49
Autor:
Ibarra Barrueta, Olatz, García Martín, Estela, López Sánchez, Piedad, Ramírez Herráiz, Esther, Merino Bohórquez, Vicente, Ais Larisgoitia, Arantza
Publikováno v:
In Farmacia Hospitalaria January-February 2023 47(1):39-49
Autor:
Esther Chamorro-de-Vega, Rosa Romero-Jiménez, Vicente Escudero-Vilaplana, Arantza Ais-Larisgoitia, María Elena Lobato Matilla, Carlos M González, Luis Menchén, Ofelia Baniandrés, Lucía Ibares-Frias, Carmen Lobo-Rodríguez, Ana Herranz-Alonso, María Sanjurjo
Publikováno v:
Journal of Medical Internet Research, Vol 24, Iss 9, p e37445 (2022)
BackgroundInformation and communication technologies (ICTs) are changing the traditional health care model and redefining personalized health. ICTs offer effective communication and real-time monitoring of patients and provide additional data to supp
Externí odkaz:
https://doaj.org/article/b2394c0319fd4347ac70b412ddc6b431
Autor:
Lobo-Rodríguez, C., Díaz-Redondo, A., Chamorro-de-Vega, E., Ais-Larisgoitia, A., Ibares-Frias, L., Baniandrés-Rodríguez, O., Menchén, L., González-Fernández, C.M.
Publikováno v:
Journal of Healthcare Quality Research; September-October 2024, Vol. 39 Issue: 5 p283-290, 8p
Autor:
Rosa Romero-Jimenez, Vicente Escudero-Vilaplana, Esther Chamorro-de-Vega, Arantza Ais-Larisgoitia, Elena Lobato-Matilla, Beatriz Somoza-Fernández, Paula Ruiz-Briones, Carlos González, Ofelia Baniandrés, Luis Menchén, Carmen Lobo-Rodríguez, Ana Herranz, María Sanjurjo
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundPharmacotherapeutic management of immune-mediated inflammatory diseases (IMID) has become more complex due to the development of new treatments, such as biological therapies. Mobile health, especially apps, can provide IMID patients with gr
Externí odkaz:
https://doaj.org/article/b51b42e375584dd6a4307adabfb26375
Autor:
Rosa Romero-Jimenez, Vicente Escudero-Vilaplana, Esther Chamorro-De-Vega, Arantza Ais-Larisgoitia, Maria Elena Lobato Matilla, Ana Herranz-Alonso, Maria Sanjurjo
Publikováno v:
Journal of Medical Internet Research, Vol 24, Iss 3, p e31016 (2022)
BackgroundImmune-mediated inflammatory diseases (IMIDs) are systemic conditions associated with a high social and health impact. New treatments have changed the prognosis of IMIDs and have increased patient autonomy in disease management. Mobile apps
Externí odkaz:
https://doaj.org/article/48ffc37596eb4d10bcd5ff68ad6a240c
Autor:
Olatz Ibarra Barrueta, Estela García Martín, Piedad López Sánchez, Esther Ramírez Herráiz, Vicente Merino Bohórquez, Arantza Ais Larisgoitia
Publikováno v:
Farmacia Hospitalaria. 47:39-49
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba64b3f7a19f7c8ea87aec545330eb63
https://doi.org/10.1016/j.farma.2022.12.005
https://doi.org/10.1016/j.farma.2022.12.005
Autor:
Olatz Ibarra Barrueta, Estela García Martín, Piedad López Sánchez, Esther Ramírez Herráiz, Vicente Merino Bohórquez, Arantza Ais Larisgoitia
Publikováno v:
Farmacia Hospitalaria. 47:T39-T49
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c38c75bbd0589e74118055842ceceff1
https://doi.org/10.1016/j.farma.2022.12.016
https://doi.org/10.1016/j.farma.2022.12.016
Autor:
Esther Ramírez, Rosa Romero‐Jiménez, Belén Hernández‐Muniesa, María Fernández‐Pacheco, Alberto Calvo, Esther Chamorro‐de‐Vega, Nuria Herrero, Bárbara Úbeda, Alberto Morell, Arantza Ais‐Larisgoitia, Elena Lobato‐Matilla, Álvaro Muñoz, Araceli Casado, Miguel Ángel Casado, Vicente Escudero‐Vilaplana
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 47:2020-2029
Immune-mediated inflammatory diseases (IMIDs) are a group of chronic and highly disabling diseases. The objective is to evaluate the satisfaction with the health care received by patients with the most prevalent IMIDs in Spain: inflammatory bowel dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d06e0c301c8425bf25608fcb4b71a881
https://doi.org/10.1111/jcpt.13742
https://doi.org/10.1111/jcpt.13742